MARC details
000 -LEADER |
fixed length control field |
04557nam a22006375i 4500 |
001 - |
control field |
978-3-030-35918-8 |
003 - |
control field |
DE-He213 |
005 - |
control field |
20211012192732.0 |
007 - |
fixed length control field |
cr nn 008mamaa |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
200219s2020 sz | s |||| 0|eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9783030359188 |
-- |
978-3-030-35918-8 |
024 7# - |
-- |
10.1007/978-3-030-35918-8 |
-- |
doi |
050 #4 - LIBRARY OF CONGRESS CALL NUMBER |
-- |
RS380 |
|
-- |
RS190-210 |
072 #7 - |
-- |
TDCW |
-- |
bicssc |
|
-- |
MED072000 |
-- |
bisacsh |
|
-- |
TDC |
-- |
thema |
082 04 - |
Classification number |
615.19 |
-- |
23 |
245 10 - TITLE STATEMENT |
Title |
Advances in Pharma Business Management and Research |
Remainder of title |
Volume 1 / |
Statement of responsibility, etc |
edited by Lars Schweizer, Theodor Dingermann, Otto Quintus Russe, Christian Jansen. |
250 ## - EDITION STATEMENT |
Edition statement |
1st ed. 2020. |
300 ## - PHYSICAL DESCRIPTION |
Extent |
X, 85 p. 11 illus. |
Other physical details |
online resource. |
505 0# - |
Formatted contents note |
Chapter 1. Introduction: Trends and developments in the pharmaceutical and life sciences industry -- Chapter 2. Relevance of instruments for measurements of Quality of Life in the AMNOG Context -- Chapter 3. The quality management system for R&D project and portfolio management in a pharmaceutical company -- Chapter 4. Brexit and Its Impact on Pharmaceutical Law - Implications for global pharma companies -- Chapter 5. Implementation of Measurable and Sustainable Actions to Improve Employee's Engagement and Business Performance - Global Medical Clinical & Regulatory Affairs (GMCRA) - A Role Model at Fresenius Kabi -- Chapter 6. Leadership Models and Work Behavior: An Empirical Analysis of Consequences of Authentic and Transformational Leadership -- Chapter 7. Alliance Management at Merck - Establishing an operational 100-day plan for alliance launches and management. |
650 #0 - |
Topical term or geographic name as entry element |
Pharmaceutical technology. |
|
Topical term or geographic name as entry element |
Health care management. |
|
Topical term or geographic name as entry element |
Health services administration. |
|
Topical term or geographic name as entry element |
Medical laws and legislation. |
|
Topical term or geographic name as entry element |
Pharmacy. |
|
Topical term or geographic name as entry element |
Pharmacy management. |
|
Topical term or geographic name as entry element |
Pharmaceutical Sciences/Technology. |
|
Topical term or geographic name as entry element |
Health Care Management. |
|
Topical term or geographic name as entry element |
Medical Law. |
|
Topical term or geographic name as entry element |
Pharmacy. |
|
Topical term or geographic name as entry element |
Pharmacoeconomics and Health Outcomes. |
700 1# - |
Personal name |
Schweizer, Lars. |
Relator term |
editor. |
|
Personal name |
Dingermann, Theodor. |
Relator term |
editor. |
|
Personal name |
Russe, Otto Quintus. |
Relator term |
editor. |
|
Personal name |
Jansen, Christian. |
Relator term |
editor. |
710 2# - |
Corporate name or jurisdiction name as entry element |
SpringerLink (Online service) |
856 40 - |
Uniform Resource Identifier |
https://doi.org/10.1007/978-3-030-35918-8 |
245 10 - TITLE STATEMENT |
-- |
[electronic resource] : |
264 #1 - |
-- |
Cham : |
-- |
Springer International Publishing : |
-- |
Imprint: Springer, |
-- |
2020. |
336 ## - |
-- |
text |
-- |
txt |
-- |
rdacontent |
337 ## - |
-- |
computer |
-- |
c |
-- |
rdamedia |
338 ## - |
-- |
online resource |
-- |
cr |
-- |
rdacarrier |
347 ## - |
-- |
text file |
-- |
PDF |
-- |
rda |
506 0# - |
-- |
Open Access |
520 ## - |
-- |
This open access book presents a unique collection of practical examples from the field of pharma business management and research. It covers a wide range of topics such as: 'Brexit and its Impact on pharmaceutical Law - Implications for Global Pharma Companies', 'Implementation of Measures and Sustainable Actions to Improve Employee's Engagement', 'Global Medical Clinical and Regulatory Affairs (GMCRA)', and 'A Quality Management System for R&D Project and Portfolio Management in a Pharmaceutical Company'. The chapters are summaries of master's theses by "high potential" Pharma MBA students from the Goethe Business School, Frankfurt/Main, Germany, with 8-10 years of work experience and are based on scientific know-how and real-world experience. The authors applied their interdisciplinary knowledge gained in 22 months of studies in the MBA program to selected practical themes drawn from their daily business. |
|
-- |
https://scigraph.springernature.com/ontologies/product-market-codes/B21010 |
|
-- |
https://scigraph.springernature.com/ontologies/product-market-codes/527030 |
|
-- |
https://scigraph.springernature.com/ontologies/product-market-codes/R16005 |
|
-- |
https://scigraph.springernature.com/ontologies/product-market-codes/F00008 |
|
-- |
https://scigraph.springernature.com/ontologies/product-market-codes/H69020 |
700 1# - |
-- |
edt |
-- |
http://id.loc.gov/vocabulary/relators/edt |
|
-- |
edt |
-- |
http://id.loc.gov/vocabulary/relators/edt |
|
-- |
edt |
-- |
http://id.loc.gov/vocabulary/relators/edt |
|
-- |
edt |
-- |
http://id.loc.gov/vocabulary/relators/edt |
773 0# - |
-- |
Springer Nature eBook |
776 08 - |
-- |
Printed edition: |
-- |
9783030359171 |
|
-- |
Printed edition: |
-- |
9783030359195 |
|
-- |
Printed edition: |
-- |
9783030359201 |
912 ## - |
-- |
ZDB-2-SBL |
|
-- |
ZDB-2-SXB |
|
-- |
ZDB-2-SOB |
950 ## - |
-- |
Biomedical and Life Sciences (SpringerNature-11642) |
|
-- |
Biomedical and Life Sciences (R0) (SpringerNature-43708) |